Bio-Path Holdings Inc logo

Bio-Path Holdings Inc

$ 3.46 +0.1 (+2.98%) 04:00 PM EST
P/E:
At Loss
P/B:
1.26
Market Cap:
$ 24.77M
Enterprise V:
$ 7.38M
Volume:
4.82K
Avg Vol (2M):
19.13K
Also Trade In:
Volume:
4.82K
Market Cap $:
24.77M
PE Ratio:
At Loss
Avg Vol (2-Month):
19.13K
Enterprise Value $:
7.38M
PB Ratio:
1.26
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.
Name Current Vs Industry Vs History
Cash-To-Debt 63.05
Equity-to-Asset 0.93
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.69
9-Day RSI 47.19
14-Day RSI 44.26
6-1 Month Momentum % -10.75
12-1 Month Momentum % -28.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.57
Quick Ratio 15.57
Cash Ratio 12.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -119.2
Name Current Vs Industry Vs History
ROE % -49.66
ROA % -47.02
ROIC % -570.84
ROC (Joel Greenblatt) % -570.84
ROCE % -49.32

Financials (Next Earnings Date:2022-11-11 Est.)

BPTH's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BPTH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.77
Beta 0.66
Volatility % 43.8
14-Day RSI 44.26
14-Day ATR ($) 0.171082
20-Day SMA ($) 3.4876
12-1 Month Momentum % -28.6
52-Week Range ($) 2.68 - 5.4
Shares Outstanding (Mil) 7.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Path Holdings Inc Filings

Document Form Filing Date
No Filing Data

Bio-Path Holdings Inc Analysis

Share your research

Headlines

See More
No news.